The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance

The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance

ABSTRACTIntratumoral bacteria flexibly contribute to cellular and molecular tumor heterogeneity for supporting cancer recurrence through poorly understood mechanisms. Using spatial metabolomic profiling technologies and 16SrRNA sequencing, we herein report that right-sided colorectal tumors are pred...

Full description

Bibliographic Details
Main Authors:	Nilmara de Oliveira Alves, Guillaume Dalmasso, Darja Nikitina, Amaury Vaysse, Richard Ruez, Lea Ledoux, Thierry Pedron, Emma Bergsten, Olivier Boulard, Lora Autier, Sofian Allam, Laurence Motreff, Pierre Sauvanet, Diane Letourneur, Pragya Kashyap, Johan Gagnière, Denis Pezet, Catherine Godfraind, Michel Salzet, Emmanuel Lemichez, Mathilde Bonnet, Imène Najjar, Christophe Malabat, Marc Monot, Denis Mestivier, Nicolas Barnich, Pankaj Yadav, Isabelle Fournier, Sean Kennedy, Amel Mettouchi, Richard Bonnet, Iradj Sobhani, Mathias Chamaillard
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Gut Microbes
Subjects:	Colibactin-producing Escherichia coli land’s cycle lipid droplet right-sided colorectal cancer
Online Access:	https://www.tandfonline.com/doi/10.1080/19490976.2024.2320291

Similar Items

Cytotoxic necrotizing factor 1 hinders colon tumorigenesis induced by colibactin-producing Escherichia coli in ApcMin/+ mice
by: Héloïse Chat, et al.
Published: (2023-12-01)

Colibactin: More Than a New Bacterial Toxin
by: Tiphanie Faïs, et al.
Published: (2018-04-01)

Colibactin-producing Escherichia coli enhance resistance to chemotherapeutic drugs by promoting epithelial to mesenchymal transition and cancer stem cell emergence
by: Guillaume Dalmasso, et al.
Published: (2024-12-01)

L-tryptophan and copper interactions linked to reduced colibactin genotoxicity in pks+ Escherichia coli
by: Charlie Bayne, et al.
Published: (2024-10-01)

The Genotoxin Colibactin Shapes Gut Microbiota in Mice
by: Sophie Tronnet, et al.
Published: (2020-08-01)

Oxygen concentration modulates colibactin production
by: Nadège Bossuet, et al.
Published: (2023-12-01)

D-Serine reduces the expression of the cytopathic genotoxin colibactin
by: Jennifer C. Hallam, et al.
Published: (2023-03-01)

Colibactin-induced damage in bacteria is cell contact independent
by: Emily Lowry, et al.
Published: (2025-01-01)

The synthesis of the novel Escherichia coli toxin—colibactin and its mechanisms of tumorigenesis of colorectal cancer
by: Guojing Zhang, et al.
Published: (2024-12-01)

The microbial genotoxin colibactin exacerbates mismatch repair mutations in colorectal tumors
by: Michael W. Dougherty, et al.
Published: (2023-09-01)

Tackling the Threat of Cancer Due to Pathobionts Producing Colibactin: Is Mesalamine the Magic Bullet?
by: Min Tang-Fichaux, et al.
Published: (2021-12-01)

Shining a Light on Colibactin Biology
by: Michael W. Dougherty, et al.
Published: (2021-05-01)

The microbiome-product colibactin hits unique cellular targets mediating host–microbe interaction
by: Walaa K. Mousa, et al.
Published: (2022-09-01)

Dysfunctional mucus structure in cystic fibrosis increases vulnerability to colibactin-mediated DNA adducts in the colon mucosa
by: Amanda Mandarino Alves, et al.
Published: (2024-12-01)

Analysis of the partial sequencing of clbA, clbB and clbQ in Escherichia coli isolates that produce colibactin and multilocus sequence typing
by: Maysaa Abdul Razzaq Dhahi
Published: (2024-08-01)

Short-term mucosal disruption enables colibactin-producing E. coli to cause long-term perturbation of colonic homeostasis
by: Christine Harnack, et al.
Published: (2023-12-01)

Inulin impacts tumorigenesis promotion by colibactin-producing Escherichia coli in ApcMin/+ mice
by: Manon Oliero, et al.
Published: (2023-02-01)

Prevalence and pathologic effects of colibactin and cytotoxic necrotizing factor-1 (Cnf 1) in Escherichia coli: experimental and bioinformatics analyses
by: Radwa N. Morgan, et al.
Published: (2019-05-01)

Genomic characterization of Escherichia coli with a polyketide synthase (pks) island isolated from ulcerative colitis patients
by: Chao Lv, et al.
Published: (2025-01-01)

Increased Epithelial Oxygenation Links Colitis to an Expansion of Tumorigenic Bacteria
by: Stephanie A. Cevallos, et al.
Published: (2019-10-01)

Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE)
by: Benoit Chassaing, et al.
Published: (2020-01-01)

Metagenomic analysis of the fecal microbiome in colorectal cancer patients compared to healthy controls as a function of age
by: Jordan Kharofa, et al.
Published: (2023-02-01)

Screening method toward ClbP-specific inhibitors
by: Tao Zhou, et al.
Published: (2023-02-01)

Targeted depletion of pks+ bacteria from a fecal microbiota using specific antibodies
by: Aitor Blanco-Míguez, et al.
Published: (2023-06-01)

Prevalence of pks + bacteria and enterotoxigenic Bacteroides fragilis in patients with colorectal cancer
by: Manon Oliero, et al.
Published: (2022-12-01)

Genetic and Functional Analysis of the pks Gene in Clinical Klebsiella pneumoniae Isolates
by: Chenshuo Luo, et al.
Published: (2023-08-01)

Cyclomodulins and Hemolysis in <i>E. coli</i> as Potential Low-Cost Non-Invasive Biomarkers for Colorectal Cancer Screening
by: Kristýna Mezerová, et al.
Published: (2021-10-01)

Prevalence of pks genotoxin among hospital-acquired Klebsiella pneumoniae
by: Amira H. El-Ashry, et al.
Published: (2022-03-01)

Microbial imbalance and intestinal pathologies: connections and contributions
by: Ye Yang, et al.
Published: (2014-10-01)

Parvimonas micra, an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes
by: Emma Bergsten, et al.
Published: (2023-12-01)

Pangenome analysis of Enterobacteria reveals richness of secondary metabolite gene clusters and their associated gene sets
by: Omkar S. Mohite, et al.
Published: (2022-09-01)

Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing Escherichia coli in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)
by: Nicolas Barnich, et al.
Published: (2022-12-01)

نقش باکتری اشریشیا کلی واجد ژن PKS بعنوان یکی از باکتریهای میکروبیوتا در دستگاه گوارش در ایجاد بیماری کولیت اولسراتیو
Published: (2014-06-01)

Contribution of pks+ <i>Escherichia coli</i> (<i>E</i>. <i>coli</i>) to Colon Carcinogenesis
by: Mohammad Sadeghi, et al.
Published: (2024-05-01)

The Limits and Avoidance of Biases in Metagenomic Analyses of Human Fecal Microbiota
by: Emma Bergsten, et al.
Published: (2020-12-01)

<i>ClbG</i> in Avian Pathogenic <i>Escherichia coli</i> Contributes to Meningitis Development in a Mouse Model
by: Peili Wang, et al.
Published: (2021-08-01)

Molecular Genetic and Functional Analysis of pks-Harboring, Extra-Intestinal Pathogenic Escherichia coli From India
by: Arya Suresh, et al.
Published: (2018-11-01)

Microbiota-derived small molecule genotoxins: host interactions and ecological impact in the gut ecosystem
by: Ellen L. Zechner, et al.
Published: (2024-12-01)

High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer.
by: Emmanuel Buc, et al.
Published: (2013-01-01)

Loss of symbiotic and increase of virulent bacteria through microbial networks in Lynch syndrome colon carcinogenesis
by: Mohammad Sadeghi, et al.
Published: (2024-02-01)